The Global Anesthesia Market was valued at USD 4.2 Bn in 2022 and is expected to reach USD 6.1 Bn by 2029, growing at a CAGR of 6.4% during the forecast period. Market growth is being driven by the rising number of surgical procedures, continuous technological advancements, and improving access to healthcare across emerging markets. The industry remains relatively consolidated, with the presence of several large established players. Some of the key companies operating in the market include Pfizer, Abbott, Baxter, and AstraZeneca.

Taxonomy

Global Anesthetic Market Ecosystem

Global Anesthesia Market Size (in USD Bn),2018-2023

The Global Anesthesia Market grew at a CAGR of 5.9% during 2018–2023, primarily driven by the rising number of surgical procedures, the growing geriatric population, and increasing demand for anesthesia drugs across healthcare settings. According to the National Center for Biotechnology Information (NCBI), around 310 million major surgeries are performed globally each year, reflecting the large procedural base supporting market demand. Although the COVID-19 pandemic temporarily disrupted this trend, with a study published in the British Journal of Surgery in May 2020 estimating that nearly 28.4 million elective surgeries were canceled or postponed worldwide over a 12-week peak disruption period, the eventual resumption of healthcare services led to the completion of these deferred procedures. This recovery phase significantly increased anesthesia drug consumption and supported the continued expansion of the global anesthesia market.

Global Anesthesia Industry Analysis

Rising Surgeries

The demand for anesthesia is closely tied to the number of surgeries performed globally. As surgical procedures continue to rise, so does the demand for anesthesia services. In addition to the rise, the population strata, old-age population, with high medical intervention rate, is also increasing. Moreover, the fastest growing segment of cosmetic and plastic surgery, according to the International Society of Aesthetic Plastic Surgery (ISAPS), the total number of surgical and non-surgical procedures increased by 11.2% globally and the rate is anticipated to climb upwards during the forecasted period.

Technological Advancements

Ongoing innovations in anesthesia delivery systems, monitoring equipment, and pharmaceuticals enhance the efficiency and safety of anesthesia administration. Development of technologies such as CRISPR-CAS9, integration of AI through machine learning and wireless technology to monitor anesthesia have led increase in precision and safe delivery. Consequently, further development and integration of technology would lead to growth in the market.

Increasing access to health care in emerging markets

Developing economies such as in Asia-Pacific, have experienced massive growth in their economies, in the past decade, and according to IMF GDP forecast it is anticipated to carry the momentum in the forecasted period. With the growth in GDP, the expenditure on health also experience a rise. And consequently, developing economies with expanding healthcare infrastructure and increasing healthcare awareness will contribute to the growth of the anesthesia market. As these regions improve their healthcare capabilities, the demand for anesthesia services tends to rise.

Global Anesthesia Market Segmentation, 2023 and 2029

Global Anesthesia Market Segmentation by Anesthesia Type (in USD Mn), 2023 and 2029

Due to versatile use of General Anesthesia, it can be used for a wide range of medical procedures, from major surgeries to diagnostic and therapeutic interventions. Its ability to allow healthcare providers to maintain control over the patient's airway, facilitating mechanical ventilation, makes it preferable.

Global Anesthesia Market Segmentation by Region (in revenue %), 2023 and 2029

The USA drives the anesthesia supply market in the North American region. This dominance could be attributed to the support by the government through investment in health sciences research. Out of the total anticipated R&D outlay, amounting to over US$200 Bn2 of the USA government in 2023, ~26% of the mammoth outlay is attributed to the Department of Health and Human Services. Europe boasts a resilient supply of anesthesia globally. The current status of Europe in this field is credited to its well-established healthcare system and a strong foundation in research and development.

Global Anesthesia Future Market Size

The Global Anesthesia Market is expected to grow at a CAGR of 6.4% during 2023–2029, supported by multiple factors beyond the rising number of surgeries. One of the key growth drivers is the increasing geriatric population, as older individuals generally require more medical interventions and surgical procedures that involve anesthesia. Technological advancements in anesthesia delivery systems, patient monitoring equipment, and anesthetic pharmaceuticals are also contributing to market expansion by improving safety, precision, and efficiency in clinical practice. In addition, the growing number of ambulatory surgical centers (ASCs) is creating new demand, as more procedures are shifting away from traditional hospital settings toward outpatient facilities where anesthesia services remain essential.

Global Anesthesia Market Players Company Profiles

Company Name	Establishment year	Description
Pfizer Inc.	1849	Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart. Currently, boasting its presence in 181 countries, providing over 80 million doses of medicine and vaccine. reaching approximately 1.3 billion patients—equivalent to 1 out of every 6 people on the planet.
Abbott Laboratories	1888	The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs. In contemporary times it sells medical devices, diagnostics, branded generic medicines and nutritional products. Abbott is the manufacturer of many popular products in the therapeutic areas of cardiovascular, diabetes, diagnostics, neuromodulation, nutrition and pharmaceuticals. Some of its well-known brands include Similac, PediaSure, Pedialyte, Brufen, Klacid, Alinity, Ensure, FreeStyle, iStat and MitraClip.
AstraZeneca plc	1999	AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom. A global, science-led, patient-focused pharmaceutical company, to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Baxter International Inc.	1931	Baxter has emerged as a leading provider of essential medical products, including intravenous (IV) solutions, medical devices, and pharmaceuticals. The company plays a critical role in the healthcare industry by supplying a diverse range of products that support patient care, from renal and hospital products to therapies for various medical conditions. With its latest tie-up with Hillrom, to ensure effective healthcare and meet the challenges of a rapidly evolving healthcare landscape.
Piramal Pharma Limited	2020	Offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization; Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products. PPL has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. In October 2020, the company received a growth equity investment from the Carlyle Group.
Glenmark Pharmaceuticals Limited	1977	With US$ 250 million+ worth out-licensing deals signed, over 1300 patents and 1400+ inventions done till date, With 141 world-class manufacturing facilities, 4 R&D centers, a vast geographical presence in over 80 countries, and a dedicated team of scientists, researchers, and medical experts, it aspire for scientific excellence, consistently adding a new dimension to pharmaceutical innovation and development. With consistent improvements in their Branded Generics, Generics, Specialty and OTC business, we are expanding our offerings across dermatology, respiratory and oncology medications to successfully move up the pharma value chain.

Global Anesthesia Market Macro-Economic Indicators

Global GDP grew by 3.8% in 2015, but dropped to -2.5% in 2020 due to the COVID-19 pandemic. It recovered to 3.5% by 2022, indicating a strong comeback despite ongoing challenges.

Between 2015 and 2022, the global urban population rose from 4 billion to 4.8 billion, while the rural population remained stable at 3.4 billion throughout. Notably, urban growth accelerated from 2015 to 2018, reaching 4.2 billion. This shift towards urban living has widespread implications for infrastructure, resource management, and socio-economic development.

Global inflation rate has risen from 4.7% in 2021 to 8.7 percent in 2022 but declined to 6.8% in 2023

Global Anesthesia Market (2023-2029)

Author

Pages

Published On

Product Code

Base Year

Summary

Market Overview

Global Anesthesia Market Overview